Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B

Lorène Seguin (1) , Max Chaffanet (2) , Séverine Garnier (2) , José Adélaïde (2) , Nadine Carbuccia (2) , Arnaud Guille (2) , Jihane Pakradouni (3) , Renaud Sabatier (2) , Cornel Popovici (2) , Daniel Birnbaum (2) , François Bertucci (2) , Anthony Goncalves (2)

1 AMU SMPM MED - Aix-Marseille Université - École de médecine
2 CRCM - Centre de Recherche en Cancérologie de Marseille
3 IPC - Institut Paoli-Calmettes

Domaines: Cancer

Lorène Seguin, Max Chaffanet, Séverine Garnier, José Adélaïde, Nadine Carbuccia, et al.. Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B. JCO precision oncology, 2019, 3, pp.1-9. ⟨10.1200/po.18.00362⟩. ⟨hal-03623688⟩